STUDY DESIGN: Women were enrolled from perinatal clinics at a safety net hospital in Denver, Colorado at <16 weeks gestation and followed prospectively through delivery. Measures of stress included: the PSS, the Center for Epidemiologic Studies Depression Scale (CESD), and the State-Trait Anxiety Inventory (STAI), completed at 16, 22, 28, 34 and 40 weeks gestation. Physiologic measures of stress included hair corticosteroid concentrations representative of 1 st , 2 nd , and 3 rd trimester total corticosteroid production and both maternal and fetal heart rate variability (HRV) measures recorded at 28-32 weeks gestation in a sub-set of participants. Maternal sociodemographic data and birth data were also collected. RESULTS: Of 221 participants, the average PSS at 16 weeks was 23 AE 8, range 4-52. The PSS at 16 weeks was negatively correlated with: birthweight (r¼-0.21, p¼0.001), and gestational age at birth (r¼-0.17, p¼0.007) and positively correlated with: trait anxiety (r¼0.59, p<0.0001) and both state anxiety (r¼0.67, p<0.0001), and maternal depressive symptoms at 16 weeks (r¼0.72, p<0.0001). No significant correlations were found between the PSS and maternal hair corticosteroids or maternal HRV measures. No correlation was noted between hair corticosteroids and HRV measures and APOs. CONCLUSION: The PSS is an important tool for assessing stress during pregnancy with elevated scores associated with adverse outcomes. It may be used to identify patients at higher risk of such outcomes in whom interventions to alleviate stress may be beneficial.
OBJECTIVE: Labor induction (IOL) may be associated with increased maternal and neonatal risks when compared to spontaneous labor. The aim of this study was to evaluate maternal and perinatal outcomes of labor induction versus spontaneous labor in pregnancies without other significant comorbidities in Kigali, Rwanda. STUDY DESIGN: Observational prospective study was conducted at the University Teaching Hospital of Kigali and Muhima District Hospital over a 6 month period from March 2017 until August 2017. These two hospitals have the largest obstetrical services in Kigali, with approximately 2500 and 7000 annual deliveries respectively. Indications for inclusion were singleton, vertex, and live pregnancies at term (> 37 weeks), with no previous uterine surgery and no underlying medical conditions. Patients who were not candidates for vaginal delivery (malpresentation, placenta previa, vaginal bleeding), had non-reassuring fetal testing before IOL or labor onset, premature rupture of membranes, oligohydramnios, growth restriction, active malaria or preeclampsia were also excluded. Gestational age was calculated from LMP and 1 st trimester ultrasound (US). If no dates were established, admission US was used. All patients had an admission US. Complications reviewed were limited to 24 hours postpartum. RESULTS: There were 1790 women who met study criteria; 1543 had spontaneous labor and 247 had IOL (13.8%). Only 8.4% of pregnancies were post term (! 42 wks). Misoprostol was the commonest method of induction used (97.1%). Labor augmentation with oxytocin was documented in 12.1% of participants. IOL was associated with a significantly higher rate of C/S than spontaneous labor, 25.1% versus 9.3% (OR¼ 3.25; 95% CI 2.32-4.55; p<0.001) and longer maternal hospital stay (p < 0.001). After controlling for site of the delivery, IOL was still associated with higher C/S rate (OR¼3.14; 95% CI 2.18-4.51; p<0.001). Postpartum hemorrhage was more common in the IOL group (3.2% versus 1.1 % (p¼0.008). APGAR score <7 after 1 min was 6.9% in IOL and 4% in spontaneous labor group (p ¼ 0.036). There was no difference in 5 minute Apgar scores or NICU admission between the groups. CONCLUSION: Induction of labor was associated with higher rates of cesarean section and postpartum hemorrhage and longer hospital stays. There was also higher rate of low Apgar score after 1 min. Health care providers should always anticipate possible complications when inducing labor. OBJECTIVE: Increasing rates of syphilis among pregnant women and their newborns raise questions concerning patient compliance, provider adherence to the current established 2015 CDC sexually transmitted infections (STI) treatment guidelines, or both. The aim of this retrospective review is to evaluate trends in the clinical management of maternal and congenital syphilis (CS) along with provider adherence to the current 2015 CDC STI guidelines in the largest tertiary care center in New Orleans, LA. STUDY DESIGN: After Institutional Review Board approval from Louisiana State University Health Sciences Center, all cases of maternal and neonatal syphilis from January 1, 2013 to December 31, 2017 at Touro Infirmary, New Orleans, LA were identified using ICD-9 and 10 codes. Women who were serofast were excluded. Maternal charts were reviewed for demographic and obstetrical variables, stage of syphilis, nontreponemal titer values and treatment regimen during pregnancy. Newborn information including birthweight, Apgars, neonatal intensive care unit admission, exam findings, nontreponenal titers, treatment regimen and other outcomes were recorded. Patient demographics and clinical characteristics were summarized by means with standard deviations, medians with minimum and maximum values, or frequencies with percentages. RESULTS: Between January 1, 2013 to December 31, 2017, 16,926 deliveries occurred at Touro Infirmary, New Orleans LA. One hundred and six mother-infant pairs diagnosed with syphilis were identified. Of these, 30 were serofast and 3 had incomplete medical records leaving 73 charts available for review. The majority (82.1%) of women were diagnosed with late latent/unknown syphilis (n¼60) at a mean gestational age of 16 weeks. Thirty-seven percent (n ¼ 26) of women received inadequate therapy according to their stage of disease, with 27% of these cases involving either erroneous dosage or incorrect medication interval. Only 15% of fetuses underwent sonographic evaluation for CS despite current recommendations for pretreatment interrogation. CONCLUSION: Consistent with national surveillance data, our findings suggest significant pitfalls in antenatal diagnosis and treatment of syphilis in pregnant women with non-adherence to the current 2015 CDC STI treatment guidelines.
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